Clinical Trials Browser

Phase 2 × Oxaliplatin × CNS × Clear all

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00091182 2013-06-05

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Phase 2 Completed

180 enrolled

CNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Astrocytoma, Carcinoma, Renal Cell, Colonic Neoplasms, Nasopharyngeal Neoplasms, Neuroblastoma, Rectal Neoplasms, Osteosarcoma, Teratoma, Testicular Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Adrenocortical Carcinoma, Optic Nerve Glioma

NCT00047177 2009-10-15

Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Phase 2 Completed

43 enrolled

CNS

Familial ependymoma, Medulloblastoma, Central Nervous System Neoplasms, Rhabdoid Tumor

NCT00407433 2009-08-07

Clinical Studies of Gemcitabine-Oxaliplatin

Phase 2 Completed

156 enrolled

CNSSarcoma

Medulloblastoma, Neuroblastoma, Osteosarcoma, Central Nervous System Neoplasms

Clinical Trials

Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Clinical Studies of Gemcitabine-Oxaliplatin